Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 63 | $2,611,566 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 350 | 242.37 | 84,830 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 382 | 243.36 | 92,964 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 258 | 244.41 | 63,058 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 189 | 245.26 | 46,354 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 77 | 246.18 | 18,956 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 7 | 247.35 | 1,731 | D |
| 05 Mar 2025 16:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 03 Mar 2025 | Sale | 1 | 248.36 | 248 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 42 | 236.51 | 9,933 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 34 | 238.33 | 8,103 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 35 | 239.18 | 8,371 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 78 | 240.32 | 18,745 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 127 | 241.51 | 30,672 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 300 | 242.44 | 72,732 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 121 | 243.23 | 29,431 | D |
| 03 Mar 2025 16:31 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2025 | Sale | 59 | 244.11 | 14,402 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 217 | 252.5 | 54,792 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 239 | 253.37 | 60,555 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 160 | 254.35 | 40,696 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 68 | 255.56 | 17,378 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 78 | 256.29 | 19,991 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 37 | 257.51 | 9,528 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 47 | 258.07 | 12,129 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 17 | 259.72 | 4,415 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 30 | 260.57 | 7,817 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 37 | 261.45 | 9,674 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 17 | 263.33 | 4,477 | D |
| 18 Feb 2025 16:47 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 14 Feb 2025 | Sale | 20 | 264.87 | 5,297 | D |
| 27 Nov 2024 17:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 26 Nov 2024 | Sale | 30 | 247.77 | 7,433 | D |
| 27 Nov 2024 17:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 26 Nov 2024 | Sale | 246 | 249.6 | 61,402 | D |
| 27 Nov 2024 17:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 26 Nov 2024 | Sale | 364 | 250.68 | 91,248 | D |
| 27 Nov 2024 17:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 26 Nov 2024 | Sale | 945 | 251.42 | 237,592 | D |
| 27 Nov 2024 17:21 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 26 Nov 2024 | Sale | 97 | 252.27 | 24,470 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 167 | 235.19 | 39,277 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 185 | 234.66 | 43,412 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 115 | 233.53 | 26,856 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 99 | 231.59 | 22,927 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 216 | 232.54 | 50,229 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 304 | 229.93 | 69,899 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 266 | 229.06 | 60,930 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 129 | 228.3 | 29,451 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 34 | 226.82 | 7,712 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 18 | 225.55 | 4,060 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 13 | 224.17 | 2,914 | D |
| 26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 59 | 221.71 | 13,081 | D |
| 29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
| 29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 17 | 157.3 | 2,674 | D |
| 29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 115 | 156.38 | 17,984 | D |
| 29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 194 | 155.45 | 30,157 | D |
| 29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 247 | 154.54 | 38,171 | D |
| 20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 16 Feb 2024 | Sale | 120 | 149.03 | 17,884 | D |
| 20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 16 Feb 2024 | Sale | 518 | 148.24 | 76,788 | D |
| 20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 16 Feb 2024 | Sale | 369 | 147.5 | 54,428 | D |
| 07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 164 | 189.31 | 31,047 | D |
| 07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 15 | 188.4 | 2,826 | D |
| 07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 86 | 187.37 | 16,114 | D |
| 07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 944 | 186.39 | 175,952 | D |
| 07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 1,593 | 185.54 | 295,565 | D |
| 07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 658 | 184.7 | 121,533 | D |
| 28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 68 | 197.08 | 13,401 | D |
| 28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 42 | 195.65 | 8,217 | D |
| 28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 414 | 194.94 | 80,705 | D |
| 28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 372 | 193.93 | 72,142 | D |
| 28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 81 | 193.18 | 15,648 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)